Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19440708rdf:typepubmed:Citationlld:pubmed
pubmed-article:19440708lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C0150369lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C1527262lld:lifeskim
pubmed-article:19440708lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:19440708pubmed:issue9lld:pubmed
pubmed-article:19440708pubmed:dateCreated2009-8-11lld:pubmed
pubmed-article:19440708pubmed:abstractText17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat-shock protein 90 (Hsp90) inhibitor, has been intensively investigated for cancer therapy and is undergoing clinical trials. Human epidermal growth factor receptor 2 (HER-2) is one of the client proteins of Hsp90 and its expression is decreased upon 17-DMAG treatment. In this study, we aimed to noninvasively monitor the HER-2 response to 17-DMAG treatment in xenografted mice.lld:pubmed
pubmed-article:19440708pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:languageenglld:pubmed
pubmed-article:19440708pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:citationSubsetIMlld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19440708pubmed:statusMEDLINElld:pubmed
pubmed-article:19440708pubmed:monthSeplld:pubmed
pubmed-article:19440708pubmed:issn1619-7089lld:pubmed
pubmed-article:19440708pubmed:authorpubmed-author:ChenXiaoyuanXlld:pubmed
pubmed-article:19440708pubmed:authorpubmed-author:NiuGangGlld:pubmed
pubmed-article:19440708pubmed:authorpubmed-author:CaoQizhenQlld:pubmed
pubmed-article:19440708pubmed:authorpubmed-author:LiZiboZlld:pubmed
pubmed-article:19440708pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19440708pubmed:volume36lld:pubmed
pubmed-article:19440708pubmed:ownerNLMlld:pubmed
pubmed-article:19440708pubmed:authorsCompleteYlld:pubmed
pubmed-article:19440708pubmed:pagination1510-9lld:pubmed
pubmed-article:19440708pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:meshHeadingpubmed-meshheading:19440708...lld:pubmed
pubmed-article:19440708pubmed:year2009lld:pubmed
pubmed-article:19440708pubmed:articleTitleMonitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab.lld:pubmed
pubmed-article:19440708pubmed:affiliationThe Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Rd, P095, Stanford, CA 94305-5484, USA.lld:pubmed
pubmed-article:19440708pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19440708pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:19440708pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19440708lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19440708lld:pubmed